University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Amber Misoprostol (Cytotec®)

Specialist initiation only - promoting healing of gastric and duodenal ulcers

Status: Red Misoprostol oral or PV

Unlicensed - oral or PV

Status: Red Mitomycin injection

For hospital use only

Status: Red Mitoxantrone injection

For hospital use only

Status: Amber Moclobemide tablets

Specialist initiation only

Status: Amber Modafinil tablets

Specialist initiation only. For treatment of narcolepsy only.

Status: Green Molnupiravir (Lagevrio®)

For eligible non-hospitalised patients (12 years and over) oral antiviral medicines are provided, following assessment, by Badger Covid Medicines Delivery Unit (CMDU), in line with NICE Technology Appraisal 878 and 1056.
Patients in the community can be referred to the Badger CMDU by their GP or NHS111
Local CMDU service information is available on BSol ICB Primary Care Hub (free registration required for access by general practice in BSol).

COVID-19 community treatment pathway, including eligibility criteria, treatment options and information on referral to Badger CMDU.
COVID-19 Medicines Delivery Unit (CMDU) Referral Form
Relevant national guidance and policy

NICE Technology Appraisal 1056: Molnupiravir for treating COVID-19
COVID-19 rapid guideline: managing COVID-19

Status: Green Mometasone furoate aqueous nasal spray

High relative cost. Second line.

Status: Red Monobenzone 20% in suitable emollient

Unlicensed special

Status: Green Morphine Sulfate orodispersible tablets (Actimorph®)

For use in Palliative patients only

Building healthier lives
Back to top